Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Aug;20(8):5684-5694.
doi: 10.1002/alz.14097. Epub 2024 Jul 5.

Effects of a multidomain intervention against cognitive decline on dementia risk profiles - Results from the AgeWell.de trial

Affiliations
Randomized Controlled Trial

Effects of a multidomain intervention against cognitive decline on dementia risk profiles - Results from the AgeWell.de trial

Andrea E Zülke et al. Alzheimers Dement. 2024 Aug.

Abstract

Introduction: Dementia risk scores constitute promising surrogate outcomes for lifestyle interventions targeting cognitive function. We investigated whether dementia risk, assessed using the LIfestyle for BRAin health (LIBRA) index, was reduced by the AgeWell.de intervention.

Methods: Secondary analyses of the AgeWell trial, testing a multicomponent intervention (including optimization of nutrition, medication, and physical, social, and cognitive activity) in older adults with increased dementia risk. We analyzed data from n = 461 participants with complete information on risk/protective factors comprised by LIBRA at the 24-month follow-up. Intervention effects on LIBRA and LIBRA components were assessed using generalized linear models.

Results: The intervention reduced LIBRA scores, indicating decreased dementia risk at follow-up (b = -0.63, 95% confidence interval [CI]: -1.14, -0.12). Intervention effects were particularly due to improvements in diet (odds ratio [OR]: 1.60, 95% CI: 1.16, 2.22) and hypertension (OR: 1.61, 95% CI: 1.19, 2.18).

Discussion: The AgeWell.de intervention reduced dementia risk. However, several risk factors did not improve, possibly requiring more intensive interventions.

Highlights: The AgeWell.de intervention reduced dementia risk according to LIfestyle for BRAin health (LIBRA) scores. Beneficial effects on LIBRA are mainly due to changes in diet and blood pressure. A pragmatic lifestyle intervention is apt to reduce dementia risk in an at-risk population.

Keywords: dementia; lifestyle; prevention; randomized controlled trial; risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests. Author disclosures are available in the supporting information.

References

    1. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer's disease. N Engl J Med. 2023;388:9‐21. - PubMed
    1. Mintun MA, Lo AC, Duggan EC, et al. Donanemab in early Alzheimer's disease. N Engl J Med. 2021;384:1691‐1704. - PubMed
    1. Kumari S, Bagri K, Deshmukh R. Chapter 2 ‐ Dementia: a journey from cause to cure. In: Gupta U, Kesharwani P, eds. Nanomedicine‐Based Approaches for the Treatment of Dementia. Academic Press; 2023:37‐56. doi:10.1016/B978-0-12-824331-2.00011-X - DOI
    1. Gustavsson A, Norton N, Fast T, et al. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimers Dement. 2023;19:658‐670. doi:10.1002/alz.12694 - DOI - PubMed
    1. Jönsson L, Wimo A, Handels R, et al. The affordability of lecanemab, an amyloid‐targeting therapy for Alzheimer's disease: an EADC‐EC viewpoint. Lancet Reg Health Eur. 2023;29:100657. - PMC - PubMed

Publication types